Search

Denise K Bonen

from Chicago, IL
Age ~71
Get Report
Also known as:
Denise Krebel Bonen, Denise C Bonen, Bonen K Bonen, Kelly C Bonen, Thomas K Bonen
Related to:
Thomas K Bonen, 76Dotan Bonen, 52Mark M Mueller, 40Kelly C Bonen, 43Timothy P Bonen, 36Daniel E Beddie, 73Scott S Richards, 44Helen L Meister, 95Frank L KrebelRyan T Bonen, 40Cecilia K Krebel
Connected to:
Lisa Bonen, 60Jennifer L Bonenberger, 54Alex Bonenfant, 32Annecy T Bonenfant, 46Brandon L Bonenfant, 29Cassandra M Bonenfant, 33Christine M Bonenfant, 48Jayson P Bonenfant, 46Nicole Bonenfant, 54

Denise Bonen Phones & Addresses

  • Chicago, IL
  • Tinley Park, IL
  • Delray Beach, FL
  • 11141 S Bell Ave, Chicago, IL 60643 (773) 844-7466

Work

Position: Precision Production Occupations

Education

Degree: High school graduate or higher

Emails

r***[email protected]

Resumes

Resumes

Denise Bonen Photo 1

Scientific Director

View page
Location:
Chicago, IL
Industry:
Pharmaceuticals
Work:
Prescott Medical Communications Group since Dec 2011
Senior Account Director
Prescott Medical Communications Group Feb 2004 - Nov 2011
Account Director
Education:
Rush University 1991
Doctor of Philosophy (PhD)
Skills:
Neurology
Pharmaceutical Industry
Medical Writing
Denise Bonen Photo 2

Denise Bonen

View page

Publications

Us Patents

Nod2 Nucleic Acids And Proteins

View page
US Patent:
20020197616, Dec 26, 2002
Filed:
Oct 26, 2001
Appl. No.:
10/002974
Inventors:
Gabriel Nunez - Ann Arbor MI, US
Naohiro Inohara - Ann Arbor MI, US
Yasunori Ogura - Ann Arbor MI, US
Judy Cho - Chicago IL, US
Dan Nicolae - Chicago IL, US
Denise Bonen - Chicago IL, US
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
The present invention relates to intracellular signalling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides isolated nucleotide sequence encoding Nod2, isolated Nod2 peptides, antibodies that specifically bind Nod2, methods for the detection of Nod2, and methods for screening compounds for the ability to alter Nod2 associated signal transduction. The present invention also provides Nod2 variant alleles. The present invention further provides methods of identifying individuals at increased risk of developing Crohn's disease.
Control profile
Denise K Bonen from Chicago, IL, age ~71 Get Report